Barry M. Deutsch
Director of Finance/CFO at Aerami Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Anne Michelle Whitaker | F | 56 |
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 6 years |
| John Stuart Patton | M | 77 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 15 years |
| Steven T. Thornton | M | 67 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 7 years |
| Joshua Ziel | M | - |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 2 years |
| Darlene M. Deptula-Hicks | F | 66 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 3 years |
| Adam Stern | M | 60 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 10 years |
| Bill Welch | M | - |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | - |
| Mei-Chang Kuo | M | 75 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 14 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Albert P. L. Stroucken | M | 76 | 4 years | |
| Gail D. Fosler | F | 76 | 4 years | |
| Kongkiat Opaswongkarn | M | 67 |
The Wharton School of the University of Pennsylvania
| 6 years |
| Ludwig Hantson | M | 61 | 1 years | |
| Amy Pott | F | 47 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 12 years |
| Beth Hecht | F | 60 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | - |
| Scott Applebaum | M | 57 | 2 years | |
| Robert Hombach | M | 58 | 1 years | |
| James R. Gavin | M | 78 | 1 years | |
| Marla Persky | F | 68 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Donna M. Walsh | F | - |
The Wharton School of the University of Pennsylvania
| 14 years |
| Eric Schwartz | M | 61 |
The Wharton School of the University of Pennsylvania
| 5 years |
| John Schmid | M | 60 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 4 years |
| Scott W. Meacham | M | 64 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 8 years |
| Lee Jeffrey Tawil | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Barbara-Jean Bormann-Kennedy | M | 65 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Scott Pinkus | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Jeffrey Sherman | M | 69 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Allison Wey | F | - |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | - |
| Matthew David Ginsburg | M | 60 |
Kellogg School of Management
| 3 years |
| Andrea Hunt | F | 64 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 29 years |
| Gregg David Pollack | M | 62 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Karen Ferrante | M | 66 | 1 years | |
| Stephanie Dorn Miller | F | 50 | 1 years | |
| Dawn Halkuff | F | 53 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Sotirios G. Stergiopoulos | M | 52 | - | |
| Christoph Brackmann | M | - | - | |
| Jacques Suzanne | F | 53 | 4 years | |
| Lisa Yañez | F | - |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 1 years |
| Jacob Wallenberg | M | 68 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Richard Philip Furst | M | 60 |
Kellogg School of Management
The Wharton School of the University of Pennsylvania
| 7 years |
| Bill Gantz | M | 86 |
OVATION Pharmaceuticals, Inc.
 OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | - |
| Robert Davis | M | 57 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 6 years |
| Marc A. Utay | M | 64 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Francois Nader | M | 67 | 1 years | |
| Jonathan Rigby | M | 56 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Ian Clark | M | 62 | 2 years | |
| Sanjiv Sobti | M | 62 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Blake E. Devitt | M | 77 | 1 years | |
| Mark Thierer | M | 64 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 1 years |
| Glenn Fuhrman | M | 58 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Patrick Enright | M | 62 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Sean Nolan | M | 56 |
OVATION Pharmaceuticals, Inc.
OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | 5 years |
| John D. Forsyth | M | 76 | 1 years | |
| Jeffrey Whitnell | M | 68 |
OVATION Pharmaceuticals, Inc.
OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | 2 years |
| Michael Barry | M | 66 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Jean-Francois van de Walle | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Andrew M. Ziolkowski | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Jonathon Jacobson | M | 62 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Laurence L. Stone | M | 59 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Yigal Dan Jhirad | M | 60 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Mindy M. Posoff | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Jeffrey Sloan | M | 56 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Andrew Richard Dym | M | 64 |
The Wharton School of the University of Pennsylvania
| 2 years |
| William Dunn | M | 58 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Stephen Baker Switzky | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| David Lane | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Marilyn Alexander | F | 72 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Eric Davis | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Marc Kozin | M | 62 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Matthew T. Mellon | M | 60 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Thierry Ho | M | 66 |
The Wharton School of the University of Pennsylvania
| 2 years |
| John Popp | M | 68 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Annette Franqui | F | 62 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Robert A. Knakal | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Frederick Wilson | M | 62 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Daniel S. Dross | M | 65 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Lisa A. Ferris | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Kirk Hachigian | M | 64 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Ken Holley | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Spencer Sherman | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Steve Lipper | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Marc David Stern | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Anna Dopkin | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Eric J. Rosen | M | 63 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Tom Hopkins | M | 67 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Kanetsugu Mike | M | 67 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Jason Chen | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Robert Bernstein | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Chris Roth | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Andy Okun | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jeff Russell | M | 67 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Ramanan Raghavendran | M | 55 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Charles Moldow | M | 58 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Craig G. Zolot | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Virginia Drosos | F | 61 |
The Wharton School of the University of Pennsylvania
| 2 years |
| David Berkman | M | 62 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Janet L. Dorman | F | 67 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Robin Josephs | F | 64 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Gary Lauder | M | 61 |
The Wharton School of the University of Pennsylvania
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 95 | 96.94% |
| Ireland | 8 | 8.16% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Barry M. Deutsch
- Personal Network
